pancreatic cancer action network logo donate now
Join our mailing list
En Español  
Search  
 
Share this Webpage!   Adjust Text Size:  P P P
Scientific Strategy
 

Viewpoints / Position Papers

As a leader in the fight against this disease, the Pancreatic Cancer Action Network provides information and commentary about scientific and medical topics.

Sutent© is the second targeted drug to be approved this month for the treatment of pancreatic neuroendocrine tumors

FOLFIRINOX shows encouraging results in pancreatic cancer

Novel noninvasive method for pancreatic cancer detection

Novartis drug approved to treat pancreatic neuroendocrine tumors

Two novel drugs recommended to be approved to treat pancreatic neuroendocrine tumors

Factors connecting inflammation to pancreatic cancer initiation and progression

Aspirin may decrease risk of pancreatic cancer

Malaria drug could be used to treat pancreatic cancer

Important genetic changes in pancreatic neuroendocrine tumors

Dr. Oz highlights pancreatic cancer on January 12th program

New test under development could detect single cancer cell in blood

New research suggests that pancreatic cancer growth rate may allow time for early detection

The Importance of Good Communication: Cell Signaling and How it Relates to Cancer

Consensus Report Offers Recommendations for Pancreatic Cancer Research Progress

Study Documents Significant Underuse of Surgical Resections

Grant Recipients Collaborate



 
  

1500 Rosecrans Avenue, Suite 200, Manhattan Beach, CA 90266
Toll Free: 877-272-6226 | Phone: 310-725-0025 | Fax: 310-725-0029
  Share This Site
Donate Now | Press | Contact Us
Site Map | Privacy Policy | Job Listings
Site Problems | Join Our Mailing List | Newsletter Survey

Our 8th Consecutive Year.

Honors the Pancreatic Cancer Action Network as
ranking in the top ten of outstanding charities.

© 2012 Pancreatic Cancer Action Network
PANCAN®, PURPLESTRIDE®, PURPLERIDE® PURPLEBOWL®, TEAMHOPE® and
PANCREATIC CANCER ACTION NETWORK® are registered trademarks.